323 related articles for article (PubMed ID: 35520949)
1. Neuroinflammation as a Potential Therapeutic Target in Alzheimer's Disease.
Liu P; Wang Y; Sun Y; Peng G
Clin Interv Aging; 2022; 17():665-674. PubMed ID: 35520949
[TBL] [Abstract][Full Text] [Related]
2. Inflammation and Alzheimer's Disease: Mechanisms and Therapeutic Implications by Natural Products.
Rather MA; Khan A; Alshahrani S; Rashid H; Qadri M; Rashid S; Alsaffar RM; Kamal MA; Rehman MU
Mediators Inflamm; 2021; 2021():9982954. PubMed ID: 34381308
[TBL] [Abstract][Full Text] [Related]
3. Multifaceted Alzheimer's Disease: Building a Roadmap for Advancement of Novel Therapies.
Kaur D; Behl T; Sehgal A; Singh S; Sharma N; Bungau S
Neurochem Res; 2021 Nov; 46(11):2832-2851. PubMed ID: 34357520
[TBL] [Abstract][Full Text] [Related]
4. Regulation of neuroinflammation in Alzheimer's disease via nanoparticle-loaded phytocompounds with anti-inflammatory and autophagy-inducing properties.
Nayak V; Patra S; Rout S; Jena AB; Sharma R; Pattanaik KP; Singh J; Pandey SS; Singh RP; Majhi S; Singh KR; Kerry RG
Phytomedicine; 2024 Jan; 122():155150. PubMed ID: 37944239
[TBL] [Abstract][Full Text] [Related]
5. p110δ PI3-Kinase Inhibition Perturbs APP and TNFα Trafficking, Reduces Plaque Burden, Dampens Neuroinflammation, and Prevents Cognitive Decline in an Alzheimer's Disease Mouse Model.
Martínez-Mármol R; Mohannak N; Qian L; Wang T; Gormal RS; Ruitenberg MJ; Vanhaesebroeck B; Coulson EJ; Meunier FA
J Neurosci; 2019 Oct; 39(40):7976-7991. PubMed ID: 31363064
[TBL] [Abstract][Full Text] [Related]
6. The N-Formyl Peptide Receptor 2 (FPR2) Agonist MR-39 Improves Ex Vivo and In Vivo Amyloid Beta (1-42)-Induced Neuroinflammation in Mouse Models of Alzheimer's Disease.
Trojan E; Tylek K; Schröder N; Kahl I; Brandenburg LO; Mastromarino M; Leopoldo M; Basta-Kaim A; Lacivita E
Mol Neurobiol; 2021 Dec; 58(12):6203-6221. PubMed ID: 34468933
[TBL] [Abstract][Full Text] [Related]
7. Phenylpropanoids and Alzheimer's disease: A potential therapeutic platform.
Kolaj I; Imindu Liyanage S; Weaver DF
Neurochem Int; 2018 Nov; 120():99-111. PubMed ID: 30098379
[TBL] [Abstract][Full Text] [Related]
8. The effects of microglia-associated neuroinflammation on Alzheimer's disease.
Wang C; Zong S; Cui X; Wang X; Wu S; Wang L; Liu Y; Lu Z
Front Immunol; 2023; 14():1117172. PubMed ID: 36911732
[TBL] [Abstract][Full Text] [Related]
9. Neuroinflammation in Alzheimer's disease: potential beneficial effects of vitamin D.
Kouba BR; Camargo A; Rodrigues ALS
Metab Brain Dis; 2023 Mar; 38(3):819-829. PubMed ID: 36862275
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
11. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
12. The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease.
Minter MR; Taylor JM; Crack PJ
J Neurochem; 2016 Feb; 136(3):457-74. PubMed ID: 26509334
[TBL] [Abstract][Full Text] [Related]
13. A Synthetic Pro-Drug Peptide Reverses Amyloid-β-Induced Toxicity in the Rat Model of Alzheimer's Disease.
Kumar S; Srivastav S; Fatima M; Giri RS; Mandal B; Mondal AC
J Alzheimers Dis; 2019; 69(2):499-512. PubMed ID: 30958369
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy against amyloid pathology in Alzheimer's disease.
Galimberti D; Ghezzi L; Scarpini E
J Neurol Sci; 2013 Oct; 333(1-2):50-4. PubMed ID: 23299047
[TBL] [Abstract][Full Text] [Related]
15. Viewpoint: Crosstalks between neurofibrillary tangles and amyloid plaque formation.
Luan K; Rosales JL; Lee KY
Ageing Res Rev; 2013 Jan; 12(1):174-81. PubMed ID: 22728532
[TBL] [Abstract][Full Text] [Related]
16. Does HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and Alzheimer's disease?
Fulop T; Witkowski JM; Larbi A; Khalil A; Herbein G; Frost EH
J Neurovirol; 2019 Oct; 25(5):634-647. PubMed ID: 30868421
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic role of boswellic acids in Alzheimer's disease: Emphasis on anti-inflammatory properties.
Siddiqui A; Shah Z; Jahan RN; Othman I; Kumari Y
Biomed Pharmacother; 2021 Dec; 144():112250. PubMed ID: 34607104
[TBL] [Abstract][Full Text] [Related]
18. Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer's Disease.
Uddin MS; Kabir MT; Niaz K; Jeandet P; Clément C; Mathew B; Rauf A; Rengasamy KRR; Sobarzo-Sánchez E; Ashraf GM; Aleya L
Molecules; 2020 Mar; 25(6):. PubMed ID: 32168835
[TBL] [Abstract][Full Text] [Related]
19. Development of grape polyphenols as multi-targeting strategies for Alzheimer's disease.
El Gaamouch F; Liu K; Lin HY; Wu C; Wang J
Neurochem Int; 2021 Jul; 147():105046. PubMed ID: 33872681
[TBL] [Abstract][Full Text] [Related]
20. Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease.
Cai Z; Hussain MD; Yan LJ
Int J Neurosci; 2014 May; 124(5):307-21. PubMed ID: 23930978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
